Jeffrey George

Jeffrey P.
George is Chairman at Lykos Therapeutics, Inc. since 2022 and at LENZ Therapeutics, Inc. since 2024.
He serves as Director at Dorian Therapeutics, Inc. since 2021, Independent Director at Amneal Intermediate, Inc. since 2019, and Independent Director at Amneal Pharmaceuticals, Inc. since 2023.
He holds director roles at Young Presidents' Organization, Dallas Chapter, and North Texas Food Bank.
He is Operating Advisor at Revival Healthcare Capital LLC.
He is Partner at Bridge Builders Collaborative since 2021 and Managing Partner at Maytal Capital LLC since 2017.
Former roles include Chief Executive Officer & Director at Performance Health Holdings, Inc. from 2018 to 2019, Chief Executive Officer at Alcon AG from 2014 to 2016, Director at WishBone Medical, Inc. from 2020 to 2022, Director at Roam Analytics, Inc. from 2017 to 2020, Independent Director at 908 Devices, Inc. from 2021 to 2025, Head-Sandoz Division at Novartis AG in 2013, Head-Emerging Markets at Novartis Pharmaceuticals Corp., Senior Director-Strategy & Business Development at Gap, Inc., Engagement Manager at McKinsey & Co., Inc. from 2001 to 2004, Chairman at Education Opens Doors, Inc., Director at Advanced Medical Technology Association.
Education includes an MBA from Harvard Business School in 2001, graduate degree from The Johns Hopkins University in 1999, and undergraduate degree from Carleton College in 1996.